[go: up one dir, main page]

UA19149A - Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу - Google Patents

Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу

Info

Publication number
UA19149A
UA19149A UA4356543A UA4356543A UA19149A UA 19149 A UA19149 A UA 19149A UA 4356543 A UA4356543 A UA 4356543A UA 4356543 A UA4356543 A UA 4356543A UA 19149 A UA19149 A UA 19149A
Authority
UA
Ukraine
Prior art keywords
crystalline
preparation
carbacephalosporin
monohydrate form
cephalosporin
Prior art date
Application number
UA4356543A
Other languages
English (en)
Russian (ru)
Inventor
Елейн Пасіні Керол
Элейн Пасини Керол
Original Assignee
Елі Ліллі Енд Компані
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елі Ліллі Енд Компані, Эли Лилли Энд Компани filed Critical Елі Ліллі Енд Компані
Publication of UA19149A publication Critical patent/UA19149A/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Винахід відноситься до способу одержання нової кристалічної форми антибіотика цефалоспоринового ряду, а саме кристалічного моногідрата 1-карбаце-фалоспорину формули , який знаходить застосування в медицині. Метою винаходу є створення нової кристалічної форми цефалоспорину, який має вищу стійкість в умовах вологості.
UA4356543A 1987-10-06 1988-10-05 Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу UA19149A (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10576687A 1987-10-06 1987-10-06

Publications (1)

Publication Number Publication Date
UA19149A true UA19149A (uk) 1997-12-25

Family

ID=22307671

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4356543A UA19149A (uk) 1987-10-06 1988-10-05 Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу

Country Status (32)

Country Link
EP (1) EP0311366B1 (uk)
JP (1) JP2641745B2 (uk)
KR (1) KR970002637B1 (uk)
CN (1) CN1029966C (uk)
AR (1) AR248407A1 (uk)
AT (1) ATE103916T1 (uk)
AU (1) AU598155B2 (uk)
BG (1) BG47036A3 (uk)
CA (1) CA1334970C (uk)
CS (1) CS270594B2 (uk)
DD (1) DD273634A5 (uk)
DE (1) DE3888913T2 (uk)
DK (1) DK170070B1 (uk)
EG (1) EG18529A (uk)
ES (1) ES2063049T3 (uk)
FI (1) FI884554A (uk)
HK (1) HK15497A (uk)
HU (1) HU206348B (uk)
IE (1) IE62108B1 (uk)
IL (1) IL87905A (uk)
MX (1) MX13277A (uk)
MY (1) MY104063A (uk)
NO (1) NO884416L (uk)
NZ (1) NZ226450A (uk)
OA (1) OA08958A (uk)
PH (1) PH31002A (uk)
PL (1) PL152022B1 (uk)
PT (1) PT88662B (uk)
SU (1) SU1731058A3 (uk)
UA (1) UA19149A (uk)
YU (1) YU46699B (uk)
ZA (1) ZA887409B (uk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU46700B (sh) * 1987-10-07 1994-04-05 Eli Lilly And Co. Kristalni monohidrat i kristalni mono- i bis (n-n'-dimetilformamid) solvati beta-laktamskog antibiotika
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5412094A (en) * 1993-06-28 1995-05-02 Eli Lilly And Company Bicyclic beta-lactam/paraben complexes
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
US6001996A (en) * 1995-05-11 1999-12-14 Eli Lilly And Company Complexes of cephalosporins and carbacephalosporins with parabens
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
DE602004018617D1 (de) 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
MXPA05009503A (es) 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
YU46700B (sh) * 1987-10-07 1994-04-05 Eli Lilly And Co. Kristalni monohidrat i kristalni mono- i bis (n-n'-dimetilformamid) solvati beta-laktamskog antibiotika

Also Published As

Publication number Publication date
JP2641745B2 (ja) 1997-08-20
MY104063A (en) 1993-11-30
MX13277A (es) 1993-11-01
DK170070B1 (da) 1995-05-15
ES2063049T3 (es) 1995-01-01
YU184588A (en) 1990-02-28
DK553788A (da) 1989-04-07
KR970002637B1 (ko) 1997-03-07
HK15497A (en) 1997-02-14
ATE103916T1 (de) 1994-04-15
PL152022B1 (en) 1990-10-31
HU206348B (en) 1992-10-28
HUT48884A (en) 1989-07-28
EG18529A (en) 1993-04-30
DE3888913T2 (de) 1994-08-11
PH31002A (en) 1997-12-23
DD273634A5 (de) 1989-11-22
PT88662B (pt) 1992-12-31
AU598155B2 (en) 1990-06-14
CA1334970C (en) 1995-03-28
EP0311366B1 (en) 1994-04-06
CN1029966C (zh) 1995-10-11
YU46699B (sh) 1994-04-05
CS666688A2 (en) 1989-11-14
DK553788D0 (da) 1988-10-04
JPH01128983A (ja) 1989-05-22
BG47036A3 (en) 1990-04-16
KR890006644A (ko) 1989-06-15
IE883015L (en) 1989-04-06
IE62108B1 (en) 1994-12-14
DE3888913D1 (de) 1994-05-11
OA08958A (en) 1990-11-30
NZ226450A (en) 1990-05-28
CN1032793A (zh) 1989-05-10
PT88662A (pt) 1988-11-01
AU2337288A (en) 1989-04-06
AR248407A1 (es) 1995-08-18
EP0311366A1 (en) 1989-04-12
SU1731058A3 (ru) 1992-04-30
NO884416D0 (no) 1988-10-05
PL275093A1 (en) 1989-05-02
FI884554A0 (fi) 1988-10-04
ZA887409B (en) 1990-06-27
IL87905A0 (en) 1989-03-31
FI884554A (fi) 1989-04-07
IL87905A (en) 1992-06-21
NO884416L (no) 1989-04-07
CS270594B2 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
UA19149A (uk) Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу
FI882253A (fi) Menetelmä kefuroksiimiaksetiilikoostumuksen valmistamiseksi
GB1405886A (en) Synergistic compositions comprising penicillin and cephalosporin antibiotics
HUT51485A (en) Process for production of immune-hindering, monoquin, especially internuclein-1-hindering medical compositions
GR862517B (en) Macrolide antibiotic derivatives
YU54189A (en) Process for obtaining cephem derivatives and midproducts for the same
PT81840A (en) Process for the production of cephem derivatives useful as antibacterial agents
UA6330A1 (uk) Спосіб одержання похідних бензаміда
ES434976A1 (es) Un procedimiento para la preparacion de un medicamento an- tibiotico.
GR3017917T3 (en) Crystalline addition salts of cephem compounds and process for their preparation.
IL113744A0 (en) 3-Cephem derivatives and their preparation
GR1002384B (el) Μεθοδος παρασκευης παραγωγων υποκατεστημενου στυρολιου.
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
FI864970A0 (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
AU3285989A (en) Treatment of infections caused by a primary immunodeficiency with interleukin-2
EP0453574A4 (en) Cephalosporin derivative
DE3463050D1 (en) Novel penem compounds, pharmaceutical compositions containing them, processes for their preparation
ES423024A1 (es) Procedimiento para la preparacion de derivados de acidos penicilanico y cefalosporanico.
DE3480542D1 (en) Cephem compounds
ZA841850B (en) 2'-desoxyoxanosine,a process for the preparation thereof and its use as a medicament
NZ220122A (en) Crystalline (5r,6s)-2-aminomethyl- -2-penem-3-carboxylic acid monohydrate, derivatives thereof, and pharmaceutical compositions
AU1009688A (en) Methods for the production of crystalline amino-protected-beta-benzyl-l-aspartic acid
HRP940557B1 (en) Process for the preparation of ceruroxime axetil as pharmaceutical preparation
IE46280L (en) Acetoxyazetidin-2-one compounds.